Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma.
Lorenc R, Shouval R, Flynn JR, Devlin SM, Saldia A, De Abia AL, De Lapuerta MC, Tomas AA, Cassanello G, Leslie LA, Rejeski K, Lin RJ, Scordo M, Shah GL, Palomba ML, Salles G, Park J, Giralt SA, Perales MA, Ip A, Dahi PB. Lorenc R, et al. Transplant Cell Ther. 2024 Oct;30(10):990-1000. doi: 10.1016/j.jtct.2024.06.027. Epub 2024 Jul 6. Transplant Cell Ther. 2024. PMID: 38972512
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
Kanis JA, Harvey NC, Lorentzon M, Liu E, Schini M, Abrahamsen B, Adachi JD, Alokail M, Borgstrom F, Bruyère O, Carey JJ, Clark P, Cooper C, Curtis EM, Dennison EM, Díaz-Curiel M, Dimai HP, Grigorie D, Hiligsmann M, Khashayar P, Lems W, Lewiecki EM, Lorenc RS, Papaioannou A, Reginster JY, Rizzoli R, Shiroma E, Silverman SL, Simonsick E, Sosa-Henríquez M, Szulc P, Ward KA, Yoshimura N, Johansson H, Vandenput L, McCloskey EV; Board of IOF, and the IOF Working Group on Epidemiology and Quality of Life. Kanis JA, et al. Among authors: lorenc rs. Osteoporos Int. 2024 Sep;35(9):1487-1496. doi: 10.1007/s00198-024-07162-w. Epub 2024 Jul 3. Osteoporos Int. 2024. PMID: 38960982 Free article.
A community health worker-led program to improve access to gestational diabetes screening in urban slums of Pune, India: Results from a mixed methods study.
Chebrolu P, Chalem A, Ponticiello M, Broderick K, Vaidyanathan A, Lorenc R, Kulkarni V, Onawale A, Mathad JS, Sundararajan R. Chebrolu P, et al. Among authors: lorenc r. PLOS Glob Public Health. 2023 Oct 27;3(10):e0001622. doi: 10.1371/journal.pgph.0001622. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37889879 Free PMC article.
Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022.
Głuszko P, Sewerynek E, Misiorowski W, Konstantynowicz J, Marcinowska-Suchowierska E, Blicharski T, Jabłoński M, Franek E, Kostka T, Jaworski M, Karczmarewicz E, Kalinka E, Księżopolska-Orłowska K, Więcek A, Lorenc RS. Głuszko P, et al. Among authors: lorenc rs. Endokrynol Pol. 2023;74(1):5-15. doi: 10.5603/EP.a2023.0012. Endokrynol Pol. 2023. PMID: 36847720 Free article. Review.
Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.
Chotiyarnwong P, McCloskey EV, Harvey NC, Lorentzon M, Prieto-Alhambra D, Abrahamsen B, Adachi JD, Borgström F, Bruyere O, Carey JJ, Clark P, Cooper C, Curtis EM, Dennison E, Diaz-Curiel M, Dimai HP, Grigorie D, Hiligsmann M, Khashayar P, Lewiecki EM, Lips P, Lorenc RS, Ortolani S, Papaioannou A, Silverman S, Sosa M, Szulc P, Ward KA, Yoshimura N, Kanis JA. Chotiyarnwong P, et al. Among authors: lorenc rs. Arch Osteoporos. 2022 Jun 28;17(1):87. doi: 10.1007/s11657-022-01117-6. Arch Osteoporos. 2022. PMID: 35763133 Free PMC article.
Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
McCloskey EV, Chotiyarnwong P, Harvey NC, Lorentzon M, Kanis JA; International Osteoporosis Foundation Epidemiology/Quality of Life Working Group. McCloskey EV, et al. Osteoporos Int. 2022 Aug;33(8):1631-1637. doi: 10.1007/s00198-022-06419-6. Epub 2022 Jun 28. Osteoporos Int. 2022. PMID: 35763073 Free article. No abstract available.
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. McClung MR, et al. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
[Actual treatment of osteoporosis].
Lorenc RS. Lorenc RS. Wiad Lek. 2019;72(9 cz 1):1641-1645. Wiad Lek. 2019. PMID: 31586976 Review. Polish.
238 results